 "investment, investment bankers, brokers, investors, company, firms, board, directors, CEOs, management, funding, tech, economy, gdp, aif, alternative investment fund, capital, startups, tech, savings, money, cash, shares, funds, equity")
Asia’s leading dialysis network, NephroPlus, has closed $25 million in a Series E round of funding to pursue growth opportunities across India and select international markets. The current round led by IIFL Asset Management (IIFL AMC) along with investment from existing investors InvestCorp and Bessemer Venture Partners (BVP). The firm said this comes on the heels of notable scale-up that the company has delivered in recent years towards maintaining its dominant market leadership in the dialysis space.
“While NephroPlus had faced few challenges during the Covid waves, our scale, diversified presence, customer connect, along with strong backward integration on costs
